Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2021

12.01.2021 | Original Article

Colorectal Cancer Screening Guidelines Are Primarily Based on Low–Moderate-Quality Evidence

verfasst von: Simcha Weissman, Alexander Goldowsky, Muhammad Aziz, Tej I. Mehta, Sachit Sharma, Megan Lipcsey, Trent Walradt, Umair Iqbal, Sameh Elias, Joseph D. Feuerstein

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Owning to colorectal cancer’s (CRC) high mortality, multiple societies developed screening guidelines.

Aims

We aimed to assess the overall quality of CRC screening guidelines.

Methods

A systematic search was performed to review CRC screening guidelines for conflicts of interest (COI), recommendation quality and strength, external document review, use of patient representative, and recommendation age—as per Institute of Medicine (IOM) standards. In addition, recommendations were compared between guidelines/societies. Statistical analysis was conducted using R.

Results

Twelve manuscripts were included in final analysis. Not all guidelines reported on COI, provided a grading method, underwent external review, or included patient representation. 14.5%, 34.2%, and 51.3% of recommendations were based on high-, moderate-, and low-quality evidence, respectively. 27.8%, 54.6%, and 17.5% of recommendations were strong, weak/conditional, and did not provide a strength, respectively. The proportion of high-quality evidence and strong recommendations did not significantly differ across societies, nor were significant associations between publication year and evidence quality seen (P = 0.4).

Conclusions

While the majority of the CRC guidelines contain aspects of the standards set forth by the IOM, there is an overall lack of adherence. As over 85% of recommendations are based on low–moderate quality evidence, further studies on CRC screening are warranted to improve the overall quality of evidence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev GastroenterolHepatol 2019;138:1–20 Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev GastroenterolHepatol 2019;138:1–20
2.
Zurück zum Zitat Levin TR, Corley DA, Jensen CD et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155:e1385 Levin TR, Corley DA, Jensen CD et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155:e1385
3.
Zurück zum Zitat Bibbins-Domingo K, Grossman DC, Curry SJ et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564–2575PubMedCrossRef Bibbins-Domingo K, Grossman DC, Curry SJ et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564–2575PubMedCrossRef
4.
Zurück zum Zitat Care CTFoPH, . Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016;188:340–348CrossRef Care CTFoPH, . Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016;188:340–348CrossRef
5.
Zurück zum Zitat Helsingen LM, Vandvik PO, Jodal HC et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367:l5515PubMedCrossRef Helsingen LM, Vandvik PO, Jodal HC et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367:l5515PubMedCrossRef
6.
Zurück zum Zitat Provenzale D, Gupta S, Ahnen DJ et al. NCCN guidelines insights: colorectal cancer screening version 1.2018. J NatlComprCancNetw 2018;16:939–949 Provenzale D, Gupta S, Ahnen DJ et al. NCCN guidelines insights: colorectal cancer screening version 1.2018. J NatlComprCancNetw 2018;16:939–949
7.
Zurück zum Zitat Leddin DJ, Enns R, Hilsden R et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol Hepatol. 2010;24:705–714 Leddin DJ, Enns R, Hilsden R et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol Hepatol. 2010;24:705–714
8.
Zurück zum Zitat Qaseem A, Crandall CJ, Mustafa RA, Hicks LA, Wilt TJ. Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians. Ann intern med. 2019;171:643–654PubMedPubMedCentralCrossRef Qaseem A, Crandall CJ, Mustafa RA, Hicks LA, Wilt TJ. Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians. Ann intern med. 2019;171:643–654PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Rex DK, Boland CR, Dominitz JA et al. Colorectal cancer screening: recommendations for physicians and patients from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:1016PubMedCrossRef Rex DK, Boland CR, Dominitz JA et al. Colorectal cancer screening: recommendations for physicians and patients from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:1016PubMedCrossRef
10.
Zurück zum Zitat Sung J, Ng S, Chan F et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132PubMedCrossRef Sung J, Ng S, Chan F et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132PubMedCrossRef
11.
Zurück zum Zitat Wolf AM, Fontham ET, Church TR et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68:250–281PubMedCrossRef Wolf AM, Fontham ET, Church TR et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68:250–281PubMedCrossRef
12.
Zurück zum Zitat Pox C, Sieg A, Altenhofen L et al. Evidenced-based guideline for colorectal cancer. GGPO 2019;2019:38–47 Pox C, Sieg A, Altenhofen L et al. Evidenced-based guideline for colorectal cancer. GGPO 2019;2019:38–47
13.
Zurück zum Zitat Alsanea N, Almadi MA, Abduljabbar AS et al. National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence. Ann Saudi Med 2015;35:189–195PubMedPubMedCentralCrossRef Alsanea N, Almadi MA, Abduljabbar AS et al. National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence. Ann Saudi Med 2015;35:189–195PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Labianca R, Nordlinger B, Beretta GD et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24:64–72CrossRef Labianca R, Nordlinger B, Beretta GD et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24:64–72CrossRef
15.
Zurück zum Zitat Lieberman D. Colon cancer screening and surveillance controversies. CurrOpinGastroenterol 2009;25:422–427 Lieberman D. Colon cancer screening and surveillance controversies. CurrOpinGastroenterol 2009;25:422–427
16.
Zurück zum Zitat Megna B, Shaukat A. Is 45 the new 50? Controversies in lowering the screening age for colorectal cancer. Baca Raton: Taylor & Francis; 2019.CrossRef Megna B, Shaukat A. Is 45 the new 50? Controversies in lowering the screening age for colorectal cancer. Baca Raton: Taylor & Francis; 2019.CrossRef
17.
Zurück zum Zitat Melmed GY, Siegel CA, Spiegel BM et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis 2013;19:662–668PubMedCrossRef Melmed GY, Siegel CA, Spiegel BM et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis 2013;19:662–668PubMedCrossRef
19.
Zurück zum Zitat Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831–841PubMedCrossRef Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831–841PubMedCrossRef
20.
Zurück zum Zitat Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D. Assessment of the quality of evidence underlying international guidelines in liver disease. Am J Gastroenterol 2012;107:1276PubMedCrossRef Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D. Assessment of the quality of evidence underlying international guidelines in liver disease. Am J Gastroenterol 2012;107:1276PubMedCrossRef
21.
Zurück zum Zitat Lee DH, Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011;171:18–22PubMedCrossRef Lee DH, Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011;171:18–22PubMedCrossRef
22.
Zurück zum Zitat Sardar P, Giri J, Jaff MR et al. Strength of evidence underlying the American Heart Association/American College of Cardiology guidelines on endovascular and surgical treatment of peripheral vascular disease. CircCardiovascInterv 2019;12:e007244 Sardar P, Giri J, Jaff MR et al. Strength of evidence underlying the American Heart Association/American College of Cardiology guidelines on endovascular and surgical treatment of peripheral vascular disease. CircCardiovascInterv 2019;12:e007244
23.
Zurück zum Zitat Duarte-García A, Zamore R, Wong JB. The evidence basis for the American College of Rheumatology practice guidelines. JAMA Intern Med 2018;178:146–148PubMedCrossRef Duarte-García A, Zamore R, Wong JB. The evidence basis for the American College of Rheumatology practice guidelines. JAMA Intern Med 2018;178:146–148PubMedCrossRef
24.
Zurück zum Zitat Brito JP, Domecq JP, Murad MH, Guyatt GH, Montori VM. The Endocrine Society guidelines: when the confidence cart goes before the evidence horse. J ClinEndocrinolMetab 2013;98:3246–3252CrossRef Brito JP, Domecq JP, Murad MH, Guyatt GH, Montori VM. The Endocrine Society guidelines: when the confidence cart goes before the evidence horse. J ClinEndocrinolMetab 2013;98:3246–3252CrossRef
25.
Zurück zum Zitat Vanclooster A, Cassiman D, Van Steenbergen W et al. The quality of hereditary haemochromatosis guidelines: a comparative analysis. Clin Res HepatolGastroenterol 2015;39:205–214CrossRef Vanclooster A, Cassiman D, Van Steenbergen W et al. The quality of hereditary haemochromatosis guidelines: a comparative analysis. Clin Res HepatolGastroenterol 2015;39:205–214CrossRef
26.
Zurück zum Zitat Feuerstein J, Akbari M, Gifford A et al. Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines. Aliment PharmacolTher 2013;37:937–946CrossRef Feuerstein J, Akbari M, Gifford A et al. Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines. Aliment PharmacolTher 2013;37:937–946CrossRef
27.
Zurück zum Zitat Field M, Lohr K. Guidelines for clinical practice: from development to use. 1992. Cited on 30. Field M, Lohr K. Guidelines for clinical practice: from development to use. 1992. Cited on 30.
28.
Zurück zum Zitat Enterprise A. AGREE: advancing the science of practice guidelines2009. Enterprise A. AGREE: advancing the science of practice guidelines2009.
29.
Zurück zum Zitat IoMCoSfDTCP Guidelines. Graham R, Mancher M. Clinical practice guidelines we can trust: National Academies Press Washington, DC; 2011. IoMCoSfDTCP Guidelines. Graham R, Mancher M. Clinical practice guidelines we can trust: National Academies Press Washington, DC; 2011.
30.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535CrossRef
31.
Zurück zum Zitat Shea BJ, Reeves BC, Wells G et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008PubMedPubMedCentralCrossRef Shea BJ, Reeves BC, Wells G et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Guyatt G, Oxman AD, Akl EA et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J ClinEpidemiol 2011;64:383–394 Guyatt G, Oxman AD, Akl EA et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J ClinEpidemiol 2011;64:383–394
33.
Zurück zum Zitat Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B. Oxford centre for evidence-based medicine level of evidence grades of recommendations (May 2001): Oxford Center; 2007. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B. Oxford centre for evidence-based medicine level of evidence grades of recommendations (May 2001): Oxford Center; 2007.
34.
Zurück zum Zitat Feuerstein JD, Pelsis JR, Lloyd S, Cheifetz AS, Stone KR. Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelines. Semin Arthritis Rheum 2016;45:379–385PubMedCrossRef Feuerstein JD, Pelsis JR, Lloyd S, Cheifetz AS, Stone KR. Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelines. Semin Arthritis Rheum 2016;45:379–385PubMedCrossRef
35.
Zurück zum Zitat Feuerstein JD, Castillo NE, Akbari M et al. Systematic analysis and critical appraisal of the quality of the scientific evidence and conflicts of interest in practice guidelines (2005–2013) for Barrett’s esophagus. Dig Dis Sci 2016;61:2812–2822PubMedCrossRef Feuerstein JD, Castillo NE, Akbari M et al. Systematic analysis and critical appraisal of the quality of the scientific evidence and conflicts of interest in practice guidelines (2005–2013) for Barrett’s esophagus. Dig Dis Sci 2016;61:2812–2822PubMedCrossRef
36.
Zurück zum Zitat McGlynn EA, Asch SM, Adams J et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635–2645PubMedCrossRef McGlynn EA, Asch SM, Adams J et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635–2645PubMedCrossRef
37.
Zurück zum Zitat Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet 2003;362:1225–1230PubMedCrossRef Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet 2003;362:1225–1230PubMedCrossRef
38.
Zurück zum Zitat Shekelle PG, Kravitz RL, Beart J, Marger M, Wang M, Lee M. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. Health Serv Res 2000;34:1429PubMedPubMedCentral Shekelle PG, Kravitz RL, Beart J, Marger M, Wang M, Lee M. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. Health Serv Res 2000;34:1429PubMedPubMedCentral
39.
Zurück zum Zitat Oxman AD, Glasziou P, Williams JW. What should clinicians do when faced with conflicting recommendations? Br Med J 2008. Oxman AD, Glasziou P, Williams JW. What should clinicians do when faced with conflicting recommendations? Br Med J 2008.
41.
Zurück zum Zitat Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines, potential benefits, limitations, and harms of guidelines. BMJ. 1999;318:527–530PubMedPubMedCentralCrossRef Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines, potential benefits, limitations, and harms of guidelines. BMJ. 1999;318:527–530PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Practitioners RCoG. The Development and Implementation of Clinical Quidelines: Report of the Clinical Quidelines Working Group: RCGP. 1995. Practitioners RCoG. The Development and Implementation of Clinical Quidelines: Report of the Clinical Quidelines Working Group: RCGP. 1995.
43.
Zurück zum Zitat Napierala H, Schäfer L, Schott G, Schurig N, Lempert T. Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch. BMC Med Ethics 2018;19:65PubMedPubMedCentralCrossRef Napierala H, Schäfer L, Schott G, Schurig N, Lempert T. Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch. BMC Med Ethics 2018;19:65PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011;343:1–8CrossRef Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011;343:1–8CrossRef
45.
Zurück zum Zitat Ghooi RB. Conflict of interest in clinical research. PerspectClin Res 2015;6:10CrossRef Ghooi RB. Conflict of interest in clinical research. PerspectClin Res 2015;6:10CrossRef
46.
Zurück zum Zitat Norris SL, Holmer HK, Ogden LA, Selph SS, Fu R. Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse. PLoS ONE 2012;7:e47343PubMedPubMedCentralCrossRef Norris SL, Holmer HK, Ogden LA, Selph SS, Fu R. Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse. PLoS ONE 2012;7:e47343PubMedPubMedCentralCrossRef
Metadaten
Titel
Colorectal Cancer Screening Guidelines Are Primarily Based on Low–Moderate-Quality Evidence
verfasst von
Simcha Weissman
Alexander Goldowsky
Muhammad Aziz
Tej I. Mehta
Sachit Sharma
Megan Lipcsey
Trent Walradt
Umair Iqbal
Sameh Elias
Joseph D. Feuerstein
Publikationsdatum
12.01.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06755-9

Weitere Artikel der Ausgabe 12/2021

Digestive Diseases and Sciences 12/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.